ライフサイエンスコーパス: intention-to-treat analyses

1 We did intention-to-treat analyses.

2 th, death, and CD4% and growth changes using intention-to-treat analyses.

3 and 93 patients to SDS, and were included in intention-to-treat analyses.

4 nresponse to treatment were determined using intention-to-treat analyses.

5 We used intention-to-treat analyses.

6 c randomized effectiveness trial design with intention-to-treat analyses.

7 bo (n=476), all of whom were included in the intention-to-treat analyses.

8 se findings were supported by the results of intention-to-treat analyses.

9 , and Hungary; all patients were included in intention-to-treat analyses.

10 weight change analyzed by both completer and intention-to-treat analyses.

11 Forty-nine participants were included in intention-to-treat analyses.

12 sample sizes, blinding, control groups, and intention-to-treat analyses.

13 We did both per-protocol and intention-to-treat analyses.

14 one dose of study drug were included in the intention-to-treat analyses.

15 omization, of whom 2482 were included in the intention-to-treat analyses.

16 2 (HSV-2) at 18 months and were assessed by intention-to-treat analyses.

17 er percentages and logrank p values are from intention-to-treat analyses.

18 o AHCT, whereas the prospective studies were intention-to-treat analyses.

19 ffect of supplement group on child growth in intention-to-treat analyses.

20 three treatment groups in both on-study and intention-to-treat analyses.

21 In the intention-to-treat analyses, a primary outcome event occ

22 Among the secondary outcomes, the intention-to-treat analyses also demonstrated that patie

23 In the intention-to-treat analyses, among patients with low-gra

24 g the Kaplan-Meier method and Cox models in "intention-to-treat" analyses and in generalized linear m

25 Intention-to-treat analyses at follow-up indicated a sig

26 randomized, 401 contributed to the modified intention-to-treat analyses at year 3 (primary outcome),

27 In intention-to-treat analyses, colorectal cancer incidence

28 In intention-to-treat analyses, colorectal cancer incidence

29 ity of studies and by lack of the following: intention-to-treat analyses, data on clinical end points

30 In the primary intention-to-treat analyses, DCS did not augment the eff

31 The intention-to-treat analyses demonstrated that patients i

32 Based on intention-to-treat analyses, DHEA therapy compared with

33 By intention-to-treat analyses, eight patients (25%) experi

34 Statistical analyses used intention-to-treat analyses for each of 77 subjects who

35 Statistical adjustments were made in intention-to-treat analyses for sex, country, age, basel

36 , 215, and 217 patients were included in the intention-to-treat analyses for TIO monotherapy, UMEC mo

37 , 214, and 212 patients were included in the intention-to-treat analyses for TIO monotherapy, VI mono

38 Intention-to-treat analyses found efficacy estimates of

39 Although intention-to-treat analyses found no effect (rate ratio

40 s were significantly improved from baseline, intention-to-treat analyses found no overall differences

41 ignificantly different between groups in the intention-to-treat analyses (HR: 0.84; 95% CI: 0.58, 1.2

42 Based on intention-to-treat analyses, HRT resulted in significant

43 Safety and intention-to-treat analyses included 259 and 255 adults

44 In intention-to-treat analyses including all randomized par

45 sing random-effects mixed-regression models, intention-to-treat analyses indicated no significant cha

46 ilevel, mixed-effects linear regression with intention-to-treat analyses is presented.SIPsmartER part

47 In intention-to-treat analyses, malaria incidence overall w

48 total of 3365 patients were included in the intention-to-treat analyses (median treatment duration,

49 Intention-to-treat analyses of 24 patients in the REP-fi

50 Intention-to-treat analyses of disability and magnetic r

51 Intention-to-treat analyses of efficacy end points were

52 We report intention-to-treat analyses of first events during the s

53 trast, in April 2001, the company's internal intention-to-treat analyses of pooled data from these 2

54 Intention-to-treat analyses on the Children's Depression

55 In intention-to-treat analyses, rates of sustained abstinen

56 Results from intention-to-treat analyses remained statistically signi

57 In intention-to-treat analyses, response rates defined acco

58 Intention-to-treat analyses revealed no difference betwe

59 Intention-to-treat analyses showed significantly greater

60 Intention-to-treat analyses showed that scores on the In

61 Intention-to-treat analyses showed that waist circumfere

62 In intention-to-treat analyses the probability of having ha

63 In intention-to-treat analyses, the mean weight loss was 4.

64 In intention-to-treat analyses, the RPS and nurse care mana

65 In intention to treat analyses, there was no difference in

66 In intention-to-treat analyses, there were no significant d

67 We performed intention-to-treat analyses to compare patients who bega

68 We used intention-to-treat analyses to compare the primary outco

69 Intention-to-treat analyses used multivariate, paired, c

70 In the intention-to-treat analyses, vaccine efficacy was 95.1%

71 Intention to treat analyses were performed for biochemis

72 Intention-to-treat analyses were also done to assess con

73 Per-protocol and modified intention-to-treat analyses were based on patients recei

74 Intention-to-treat analyses were conducted.

75 Intention-to-treat analyses were done at 9- and 18-month

76 Intention-to-treat analyses were done with linear regres

77 Both on-treatment and intention-to-treat analyses were done.

78 Intention-to-treat analyses were performed at T0 (baseli

79 Intention-to-treat analyses were performed.

80 Modified intention-to-treat analyses were performed.

81 Analyses of covariance based on intention-to-treat analyses were used to compare the 2 g

82 Similar efficacy was seen in the intention-to-treat analyses, which showed a vaccine effi

83 We did intention-to-treat analyses with no extrapolation.

84 Although in the short-term, intention-to-treat analyses yielded some statistically s